
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Human Chorionic Gonadotropin
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase IV
Recipient : Genuine Research Center, Egypt
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Human Chorionic Gonadotrophin is a Hormone drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Infertility, Female.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
October 27, 2020
Lead Product(s) : Human Chorionic Gonadotropin
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase IV
Recipient : Genuine Research Center, Egypt
Deal Size : Inapplicable
Deal Type : Inapplicable
